NCT00083434终止3 期
Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 试验地点
- 12
研究概览
简要总结
The purpose of this study is to examine the effectiveness of epoetin alfa in treating anemia in patients who have cancer or who no longer have any signs of the cancer, but remain anemic as a result of their treatment.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age or older
- •Body weight >/= 99lbs
- •Anemia results from cancer, chemotherapy, radiotherapy or an association with hormonal therapy or immunotherapy
- •Screening hemoglobin level of </= 11.0 g/dL for men or </= 10.0 for women
排除标准
- •History of or concurrent second malignancy
- •Evidence of primary or metastatic malignancy involving the Central Nervous System
研究者
研究点 (12)
Loading locations...
相似试验
终止
3 期
Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or RadiotherapyAnemiaNCT00083486Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
已完成
不适用
Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)NeoplasmsAnemiaNCT00398749Janssen-Cilag B.V.1,927
已完成
不适用
Anemia profile in cancer patientsCTRI/2018/09/015667BLK SuperSpeciality Hospital350
终止
不适用
Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic SyndromeMyelodysplastic SyndromesAnemiaHemopathiesNCT01546337Rennes University Hospital30
已完成
2 期
Erythropoietin for Management of Anemia Caused by ChemotherapyDiffuse Large B-cell LymphomaNCT02890602Kosin University Gospel Hospital53